BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

541 related articles for article (PubMed ID: 8648381)

  • 1. Improved survival for children with B-cell acute lymphoblastic leukemia and stage IV small noncleaved-cell lymphoma: a pediatric oncology group study.
    Bowman WP; Shuster JJ; Cook B; Griffin T; Behm F; Pullen J; Link M; Head D; Carroll A; Berard C; Murphy S
    J Clin Oncol; 1996 Apr; 14(4):1252-61. PubMed ID: 8648381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disseminated nonlymphoblastic lymphoma of childhood: a Childrens Cancer Group study, CCG-552.
    Finlay JL; Anderson JR; Cecalupo AJ; Hutchinson RJ; Kadin ME; Kjeldsberg CR; Provisor AJ; Woods WG; Meadows AT
    Med Pediatr Oncol; 1994; 23(6):453-63. PubMed ID: 7935170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HiC-COM: a 2-month intensive chemotherapy regimen for children with stage III and IV Burkitt's lymphoma and B-cell acute lymphoblastic leukemia.
    Schwenn MR; Blattner SR; Lynch E; Weinstein HJ
    J Clin Oncol; 1991 Jan; 9(1):133-8. PubMed ID: 1985162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 'MACHO' chemotherapy for stage IV B cell lymphoma and B cell acute lymphoblastic leukaemia of childhood. United Kingdom Children's Cancer Study Group (UKCCSG).
    Hann IM; Eden OB; Barnes J; Pinkerton CR
    Br J Haematol; 1990 Nov; 76(3):359-64. PubMed ID: 2261346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Studies of childhood non-Hodgkin's lymphoma--treatment results with the CCLSG NHL 960 protocol. Children's Cancer and Leukemia Study Group (CCLSG)].
    Tsurusawa M; Katano N; Hirota T; Ito M; Yanase T; Asami K; Koizumi S; Nakayama M; Miyawaki T; Suzumiya J; Nishikawa K; Mugisima H; Horikoshi Y; Hatae Y; Iwai A; Anami K; Kikuchi M; Osima K; Kaneko Y; Kataoka S; Tanaka A; Chin M; Taga T; Watanabe A; Fujimoto T
    Rinsho Ketsueki; 1998 Nov; 39(11):1092-8. PubMed ID: 9866420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of high-dose cytarabine during interval therapy of a Berlin-Frankfurt-Munster-based protocol in increased-risk children with acute lymphoblastic leukemia and lymphoblastic lymphoma: results of the European Organization for Research and Treatment of Cancer 58881 randomized phase III trial.
    Millot F; Suciu S; Philippe N; Benoit Y; Mazingue F; Uyttebroeck A; Lutz P; Mechinaud F; Robert A; Boutard P; Marguerite G; Ferster A; Plouvier E; Rialland X; Behard C; Plantaz D; Dresse MF; Philippet P; Norton L; Thyss A; Dastugue N; Waterkeyn C; Vilmer E; Otten J;
    J Clin Oncol; 2001 Apr; 19(7):1935-42. PubMed ID: 11283125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extended intrathecal methotrexate may replace cranial irradiation for prevention of CNS relapse in children with intermediate-risk acute lymphoblastic leukemia treated with Berlin-Frankfurt-Münster-based intensive chemotherapy. The Associazione Italiana di Ematologia ed Oncologia Pediatrica.
    Conter V; Aricò M; Valsecchi MG; Rizzari C; Testi AM; Messina C; Mori PG; Miniero R; Colella R; Basso G
    J Clin Oncol; 1995 Oct; 13(10):2497-502. PubMed ID: 7595699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fractionated cylophosphamide and back to back high dose methotrexate and cytosine arabinoside improves outcome in patients with stage III high grade small non-cleaved cell lymphomas (SNCCL): a randomized trial of the Pediatric Oncology Group.
    Brecher ML; Schwenn MR; Coppes MJ; Bowman WP; Link MP; Berard CW; Shuster JJ; Murphy SB
    Med Pediatr Oncol; 1997 Dec; 29(6):526-33. PubMed ID: 9324339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High survival rate in advanced-stage B-cell lymphomas and leukemias without CNS involvement with a short intensive polychemotherapy: results from the French Pediatric Oncology Society of a randomized trial of 216 children.
    Patte C; Philip T; Rodary C; Zucker JM; Behrendt H; Gentet JC; Lamagnère JP; Otten J; Dufillot D; Pein F
    J Clin Oncol; 1991 Jan; 9(1):123-32. PubMed ID: 1985161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapy of B-cell acute lymphoblastic leukaemia in childhood: the BFM experience.
    Reiter A
    Baillieres Clin Haematol; 1994 Jun; 7(2):321-37. PubMed ID: 7803904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of treatment of advanced-stage Burkitt's lymphoma and B cell (SIg+) acute lymphoblastic leukemia with high-dose fractionated cyclophosphamide and coordinated high-dose methotrexate and cytarabine.
    Murphy SB; Bowman WP; Abromowitch M; Mirro J; Ochs J; Rivera G; Pui CH; Fairclough D; Berard CW
    J Clin Oncol; 1986 Dec; 4(12):1732-9. PubMed ID: 3491184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 2000 Burkitt lymphoma trial in Malawi.
    Hesseling P; Broadhead R; Mansvelt E; Louw M; Wessels G; Borgstein E; Schneider J; Molyneux E
    Pediatr Blood Cancer; 2005 Mar; 44(3):245-50. PubMed ID: 15547922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eighty-one percent event-free survival in advanced Burkitt's lymphoma/leukemia: no differences in outcome between pediatric and adult patients treated with the same intensive pediatric protocol.
    Todeschini G; Tecchio C; Degani D; Meneghini V; Marradi P; Balter R; Zanotti R; Ricetti M; Franchini M; Perona G
    Ann Oncol; 1997; 8 Suppl 1():77-81. PubMed ID: 9187436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved outcome in adult B-cell acute lymphoblastic leukemia.
    Hoelzer D; Ludwig WD; Thiel E; Gassmann W; Löffler H; Fonatsch C; Rieder H; Heil G; Heinze B; Arnold R; Hossfeld D; Büchner T; Koch P; Freund M; Hiddemann W; Maschmeyer G; Heyll A; Aul C; Faak T; Kuse R; Ittel TH; Gramatzki M; Diedrich H; Kolbe K; Fuhr HG; Fischer K; Schadeck-Gressel C; Weiss A; Strohscheer I; Metzner B; Fabry U; Gökbuget N; Völkers B; Messerer D; Uberla K
    Blood; 1996 Jan; 87(2):495-508. PubMed ID: 8555471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Favorable outcome of B-cell acute lymphoblastic leukemia in childhood: a report of three consecutive studies of the BFM group.
    Reiter A; Schrappe M; Ludwig WD; Lampert F; Harbott J; Henze G; Niemeyer CM; Gadner H; Müller-Weihrich S; Ritter J
    Blood; 1992 Nov; 80(10):2471-8. PubMed ID: 1421370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Teniposide plus cytarabine as intensification therapy and in continuation therapy for advanced nonlymphoblastic lymphomas of childhood.
    Maluf PT; Odone Filho V; Cristofani LM; Britto JL; Almeida MT; Pontes E; Maksoud JG; Manissadjian A
    J Clin Oncol; 1994 Sep; 12(9):1963-8. PubMed ID: 8083717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small noncleaved cell lymphoma and leukemia in adults. A retrospective study of 65 adults treated with the LMB pediatric protocols.
    Soussain C; Patte C; Ostronoff M; Delmer A; Rigal-Huguet F; Cambier N; Leprisé PY; François S; Cony-Makhoul P; Harousseau JL
    Blood; 1995 Feb; 85(3):664-74. PubMed ID: 7833470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-Hodgkin's lymphomas of childhood and adolescence: results of a treatment stratified for biologic subtypes and stage--a report of the Berlin-Frankfurt-Münster Group.
    Reiter A; Schrappe M; Parwaresch R; Henze G; Müller-Weihrich S; Sauter S; Sykora KW; Ludwig WD; Gadner H; Riehm H
    J Clin Oncol; 1995 Feb; 13(2):359-72. PubMed ID: 7844597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of treatment regimens for pediatric lymphoblastic non-Hodgkin's lymphoma: a Childrens Cancer Group study.
    Tubergen DG; Krailo MD; Meadows AT; Rosenstock J; Kadin M; Morse M; King D; Steinherz PG; Kersey JH
    J Clin Oncol; 1995 Jun; 13(6):1368-76. PubMed ID: 7751881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intensive, very short-term chemotherapy for advanced Burkitt's lymphoma in children.
    Spreafico F; Massimino M; Luksch R; Casanova M; Cefalo GS; Collini P; Ferrari A; Polastri D; Terenziani M; Gasparini M; Fossati-Bellani F
    J Clin Oncol; 2002 Jun; 20(12):2783-8. PubMed ID: 12065554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.